Two-stage drug approval would reduce the risks.
Frantz
John A
JA
D000900:Anti-Bacterial Agents / Q000600:supply & distribution; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data*; D003254:Consumer Advocacy; D017277:Drug Approval / Q000191:economics / Q000379:methods*; D004345:Drug Industry / Q000191:economics; D006801:Humans; D010330:Patents as Topic; D011358:Product Surveillance, Postmarketing; D040242:Risk Reduction Behavior; D017211:Treatment Failure; D014481:United States; D014486:United States Food and Drug Administration / Q000592:standards*
D000900:Anti-Bacterial Agents